Quick Links
- Clinician Update
- User Portal Terms & Conditions
- Terms & Conditions
- Website Terms of Use
- Shareholder Documents
- T1CMR Phantom Order Form
- Clinical Trials: Adding a new MRI scanner
- Sign up
- Change your portal registered user details
- Adding a new MRI scanner
- Sign up – New User
- Coming Soon
- Cardiac T2 Specifications
- HepaFat-Scan® Specifications
- HepaFat-Scan®
- HepaFat-Al® Specifications
- HepaFat-Al®
- FerriSmart Specifications
- FerriSmart™
- Ferriscan Resources
- Ferriscan Specification
- FerriScan©
- Phantom
- ASX Announcements
- Annual Reports
- ASX Information
- Careers
- Board and Management Team
- Cardiac T2* ®
- LiverSmart ™
- About
- Products
- Privacy
- What is Iron Overload?
- Patients
- How to become a Resonance Health customer?
- Physicians
- Contact Us
- Events
- Investors
- Locations
- Clinical Trials
- Home
News & Events
- Clinician Update – March 2023
- FerriScan® is now available on 3T MRI scanners!
- ACG 2022 Annual Scientific Meeting
- ASX Announcements 2022
- Thalassaemia International Federation To Deploy Ferrismart
- THALASSEMIA INTERNATIONAL FEDERATION TO DEPLOY FERRISMART
- Introducing Liversmart: A New Ai Medical Device
- Introducing LiverSmart: A New AI Medical Device
- ACG 2021 Annual Scientific Meeting
- Easl Digital #Nafldsummit 2021: Resonance Health Presents, Hepafat-ai Results Equivalent To A Conventional Mrs Technique
- EASL Digital #NAFLDSummit 2021: Resonance Health presents, HepaFat-AI results equivalent to a conventional MRS technique
- Appointment Of Gm – Global Sales & Marketing
- Appointment of GM – Global Sales & Marketing
- ACG 2021 Annual Scientific Meeting
- Resonance Health News – June 2021
- Resonance Health News – June 2021
- Appointment Of Chief Financial Officer & Company Secretary
- Appointment of Chief Financial Officer & Company Secretary
- Phantoms
- Hepafat-ai Receives Ce Marking
- HepaFat-AI Receives CE Marking
- HepaFat-AI Receives TGA Approval
- ASX Announcements 2021
- HepaFat-AI gains US FDA clearance
- R&D Update: New Pulmonary Embolism AI Solution Developed
- Execution of Licence Agreement with Telethon Kids Institute and Erasmus University Medical Centre
- Resonance Health Files New Provisional Patent
- Resonance Health News – April 2020
- ASX Announcements 2020
- Resonance Health Partners with Siemens Healthineers
- New Artificial Intelligence Tool for Automated Assessment of Liver Fat
- Resonance Health Files Provisional Patent
- International Thalassaemia Day
- Resonance Health News – April 2019
- Distribution Agreement with EnvoyAI
- ASX Announcements 2019
- FDA Clearance Granted for FerriSmart
- TGA, CE Mark clearance for A.I. Solution FerriSmart
- Alliance Partner Agreement with Blackford Analysis
- Resonance Health News – June 2018
- European Hematology Association Congress
- UK Forum on Haemoglobin Disorders
- Resonance announces Deal to distribute Diabetic Retinopathy AI tool
- European Hematology Association Congress
- The 6th Symposium HEMATOLOGY TODAY
- BSH 58th Annual Scientific Meeting
- European Association for the Study of the Liver & The Liver Forum 2018
- UK Forum on Haemoglobin Disorders
- Resonance Health News – March 2018
- Resonance Health appoints new Non-Executive Director
- Mr Mitchell Wells
- Global NASH Congress 2018
- Resonance Health announce new CEO
- ASX Announcements 2018
- The 6th Symposium Hematology Today
- Resonance Health News – December 2017
- American Society Of Hematology – Annual Meeting & Exposition
- 14th International Conference on Thalassaemia & Haemoglobinopathies
- Collaborative Partnership commences to develop new AI diagnostic tools
- Resonance Health News – September 2017
- Bone Marrow R2-MRI
- Resonance Health News – June 2017
- Uncertainty over Serum Ferritin in Cancer Survivors
- European Hematology Association (EHA) Congress
- TIF MEDIA RELEASE & CLINICAL ALERT
- Conference Round-up
- UK Forum on Haemoglobin Disorders
- Newborn Screening for Haemoglobinopathies
- Sickle Cell Disease Research & Educational Symposium
- FerriScan® Results Are Not Confounded by Liver Fat
- European Association for the Study of the Liver & The Liver Forum 2017
- FerriScan: Patient Management Guidelines
- Genetic Haemochromatosis Conference
- Resonance Health News – March 2017
- Survey Results: Transfusional Iron Overload and Cancer Survivors
- Cancer Survivorship Conferences
- BSH 57th Annual Scientific Meeting
- Cancer Survivorship Symposium
- American Society of Hematology (ASH) Annual Meeting Update
- American Society of Hematology – Annual Meeting & Exposition
- Analyst Coverage
- American Association for the Study of Liver Diseases Conference
- The Late Medical Effects of Cancer Treatments
- Results Published Recommending Use of FerriScan in Sickle Cell Disease
- London Blood Transfusion Forum and Education Event
- Guys and St Thomas Sickle Cell Conference
- Resonance Health News – September 2016
- Iron Overload in Cancer Survivors
- Sickle Cell Disease Association of America – Sickle Cell Convention
- Resources
- New FerriScan Video – A Clinician’s Perspective
- Iron Monitoring in Cancer Survivors – Clinician Survey
- Childhood Cancer Conference 2016
- Australasian Haemochromatosis Conference
- Video Launch: “FerriScan – the Gold Standard in Liver Iron Measurement”
- European Hematology Association (EHA) Congress
- 10th Sickle Cell in Focus Conference
- Conference Showcase – April & May 2016
- Perth Biotech Pioneer Receives International Award
- UK Forum on Haemoglobin Disorders
- International Workshop on NASH Biomarkers
- Genetic Haemochromatosis UK National Conference
- HÄMATOLOGIE HEUTE Symposium on Sickle Cell Disease
- International Society of Haematology World Congress
- Sickle Cell Disease Research & Educational Symposium
- European Association for the Study of the Liver & the Liver Forum
- Resonance Health News – March 2016
- Publication Snapshot
- Resonance Health in the Media
- Sherif Boulos
- Michael House
- FerriScan Recognised for Contribution to Global Health Issue
- Resonance Health News December 2015
- FerriScan Case Study Challenge
- American Society of Hematology Annual Meeting 2015
- 30,000 FerriScans and ASH
- American Association for the Study of Liver Disease 2015
- Sickle Cell & Thalassemia Advanced Conference
- Resonance Health News September 2015
- Dr Wenjie Pang
- Thalassaemia International Federation Pan-Asia Conference 2015
- Lifelines: The 2015 Pan-Canadian Thalassemia Conference
- Resonance Health Appoints New Distributor, KNS in Canada
- Sickle Cell Disease Association of America Annual Convention 2015
- ANZHPBA Annual Meeting 2015
- St Mary’s Hospital Celebrates 1000 FerriScans From Perth to Paddington!
- HEPAFAT-SCAN® FATTY LIVER STUDY COMMENCES IN THE USA
- Entrepreneur of the Year Award – Western Region Technology Winner!
- Conference Update: China Symposium on NAFLD in Shanghai
- Conference Update: Showcasing Resonance Health in Europe
- Symposium on Liver Disease and Metabolism
- Digestive Disorders Federation / BASL Meeting 2015
- Resonance Health News June 2015
- LIC-NET Italy Advances Best Practice in Iron Monitoring
- FerriScan Funding Signals End to Liver Biopsy for Scottish Haemoglobinopathy Patients
- Resonance Health Partners with CSIRO
- Sickle Cell in Focus 2015
- European Hematology Association (EHA) Congress 2015
- Advances for Resonance Health in Measurement of Liver Fibrosis
- US study addressing fatty liver disease in children using HepaFat-Scan® technology
- UK Forum on Haemoglobin Disorders
- Prof. Tim St Pierre Presenting at Licnet Conference in Italy
- Resonance Health Exhibiting at EASL
- Resonance Health News March 2015
- Subscribe to Receive Our Newsletters
- Patient Information
- Clinician Information
- About Us
- Share Price
- ASX subscribe
- ASX Announcements 2017
- ASX Announcements 2016
- ASX Announcements 2004
- ASX Announcements 2005
- ASX Announcements 2006
- ASX Announcements 2012
- ASX Announcements 2007
- ASX Announcements 2008
- ASX Announcements 2009
- ASX Announcements 2010
- ASX Announcements 2011
- ASX Announcements 2013
- ASX Announcements 2014
- ASX Announcements 2015
- Products
- HepaFat-Scan® Information for Patients
- HepaFat-Scan® Information for Clinicians
- Fatty Liver Disease
- HepaFat-Scan® – MRI Measurement of Liver Fat
- Reimbursement
- FerriScan® Information for Patients
- FerriScan® Information for Clinicians
- Easy Setup for Radiology Centres
- Iron Overload
- Cardiac T2* with FerriScan® – Dual Analysis Service
- FerriScan® – MRI Measurement of Liver Iron Concentration
- Annual Reports
- Business Overview
- Contact Us
- Quality Assured Service Delivery
- Mr Nick Allan
- Dr Travis Baroni
- Mr Simon Panton
- Dr Martin Blake
- Board and Management Team
- Find A Centre
- Find A Centre
- Find A Centre
- Find A Centre
- Clinical Trial Services – for Pharmaceutical Companies
- ASH Abstract commends FerriScan as “crucial”
- FerriScan And Cardiac T2* Services Showcased In Europe
- Resonance Health exhibits at AASLD – the world’s largest meeting of liver specialists
- Resonance Health – 2014 WA Innovator of the Year Overall Winner
- Resonance Health is Exhibiting at BASL
- Website Disclaimer